{
  "ticker": "CRL",
  "last_updated": "2025-06-05T08:34:28.500929",
  "retention_years": 3,
  "count": 17,
  "transactions": [
    {
      "id": 364,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barg Steven",
      "reporting_owner_cik": "0001852883",
      "reporting_owner_position": null,
      "transaction_date": "2025-06-02",
      "transaction_shares": "481",
      "transaction_price": "135.04",
      "transaction_type": "A",
      "shares_after_transaction": "481"
    },
    {
      "id": 367,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Graves Paul W",
      "reporting_owner_cik": "0001559551",
      "reporting_owner_position": null,
      "transaction_date": "2025-06-02",
      "transaction_shares": "946",
      "transaction_price": "135.04",
      "transaction_type": "A",
      "shares_after_transaction": "946"
    },
    {
      "id": 375,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Ceesay Abraham",
      "reporting_owner_cik": "0001722140",
      "reporting_owner_position": null,
      "transaction_date": "2025-06-02",
      "transaction_shares": "946",
      "transaction_price": "135.04",
      "transaction_type": "A",
      "shares_after_transaction": "946"
    },
    {
      "id": 376,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Enyedy Mark J",
      "reporting_owner_cik": "0001586965",
      "reporting_owner_position": null,
      "transaction_date": "2025-06-02",
      "transaction_shares": "946",
      "transaction_price": "135.04",
      "transaction_type": "A",
      "shares_after_transaction": "946"
    },
    {
      "id": 366,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2025-05-30",
      "transaction_shares": "17253",
      "transaction_price": "135.63",
      "transaction_type": "A",
      "shares_after_transaction": "210685"
    },
    {
      "id": 368,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2025-05-30",
      "transaction_shares": "5603",
      "transaction_price": "135.63",
      "transaction_type": "A",
      "shares_after_transaction": "13102"
    },
    {
      "id": 371,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2025-05-30",
      "transaction_shares": "6252",
      "transaction_price": "135.63",
      "transaction_type": "A",
      "shares_after_transaction": "22482"
    },
    {
      "id": 372,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2025-05-30",
      "transaction_shares": "6709",
      "transaction_price": "135.63",
      "transaction_type": "A",
      "shares_after_transaction": "25856"
    },
    {
      "id": 374,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2025-05-30",
      "transaction_shares": "2064",
      "transaction_price": "135.63",
      "transaction_type": "A",
      "shares_after_transaction": "10807"
    },
    {
      "id": 377,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2025-05-30",
      "transaction_shares": "12239",
      "transaction_price": "135.63",
      "transaction_type": "A",
      "shares_after_transaction": "66227"
    },
    {
      "id": 378,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Pease Flavia",
      "reporting_owner_cik": "0001924996",
      "reporting_owner_position": "Corporate Executive VP & CFO",
      "transaction_date": "2025-05-30",
      "transaction_shares": "7152",
      "transaction_price": "135.63",
      "transaction_type": "A",
      "shares_after_transaction": "17482"
    },
    {
      "id": 362,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2025-05-26",
      "transaction_shares": "161",
      "transaction_price": "136.73",
      "transaction_type": "F",
      "shares_after_transaction": "19352"
    },
    {
      "id": 363,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2025-05-26",
      "transaction_shares": "104",
      "transaction_price": "136.73",
      "transaction_type": "F",
      "shares_after_transaction": "7608"
    },
    {
      "id": 365,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2025-05-26",
      "transaction_shares": "281",
      "transaction_price": "136.73",
      "transaction_type": "F",
      "shares_after_transaction": "54347"
    },
    {
      "id": 369,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2025-05-26",
      "transaction_shares": "50",
      "transaction_price": "136.73",
      "transaction_type": "F",
      "shares_after_transaction": "8805"
    },
    {
      "id": 370,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Pease Flavia",
      "reporting_owner_cik": "0001924996",
      "reporting_owner_position": "Corporate Executive VP & CFO",
      "transaction_date": "2025-05-26",
      "transaction_shares": "190",
      "transaction_price": "136.73",
      "transaction_type": "F",
      "shares_after_transaction": "10471"
    },
    {
      "id": 373,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2025-05-26",
      "transaction_shares": "123",
      "transaction_price": "136.73",
      "transaction_type": "F",
      "shares_after_transaction": "16383"
    }
  ]
}